Medimmune Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 03/31/07 Q1

ended 12/31/06 FY 2006 – amended

ended 12/31/06 FY 2006

ended 09/30/06 Q3

ended 06/30/06 Q2

Prospectuses and Registrations Filter

Securities registration termination

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Cavanaugh James H

Mathers Edward T

News Filter

Announces Make-Whole Fundamental Change Relating to Its 1.375% Convertible Senior Notes Due 2011 and 1.625% Convertible Senior Notes Due 2013

Successful Astrazeneca Tender Offer for Medimmune Shares

Announces Convertibility of 1.375% Convertible Senior Notes Due 2011 and 1.625% Convertible Senior Notes Due 2013

Reports Financial Results for 2007 First Quarter

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Preliminary proxy

Other Filter

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission